3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Sarcoma
2
Lymphoid
1
Conditions
Sarcoma
11
Osteosarcoma
4
Gastrointestinal Stromal Tumors
3
Gastrointestinal Neoplasms
3
Central Nervous System Neoplasms
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Thyroid Neoplasms
2
Oligodendroglioma
2
Meningioma
2
Melanoma
2
Medulloblastoma
2
Lymphoma
2
Hemangiosarcoma
2
Gliosarcoma
2
Glioma
2
Glioblastoma
2
Ependymoma
2
Brain Neoplasms
2
Bone Neoplasms
2
Astrocytoma
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Stomach Neoplasms
1
Spinal Cord Neoplasms
1
Radiation Injuries
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Plexosarcoma
1
Pituitary Neoplasms
1
Interventions
Doxorubicin
18
Ifosfamide
13
Radiotherapy
8
Paclitaxel
7
pazopanib
6
pembrolizumab
4
Gemcitabine
4
Filgrastim
4
Chemotherapy, Adjuvant
4
Bevacizumab
4
spartalizumab
3
durvalumab
3
Sorafenib
3
Propranolol
3
Nivolumab
3
Ipilimumab
3
Imatinib Mesylate
3
Etoposide
3
Epirubicin
3
Docetaxel
3
Carboplatin
3
trebananib
2
regorafenib
2
cixutumumab
2
cemiplimab
2
carotuximab
2
brostallicin
2
belinostat
2
balstilimab
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Hemangiosarcoma
×
Surveys and Questionnaires
×
Sarcoma
×
Clear all
NCT06535997
2025-08-06
PRIMHADRON
Hospices Civils de Lyon
Completed
62 enrolled
NCT01786889
2016-07-29
ANGIHE
Centre Oscar Lambret
Phase NA
Unknown
9 enrolled